Benefit and Risk Information for Medication in Multiple Sclerosis (BRIMMS). / Reen, Gurpreet.

2017.

Research output: ThesisDoctoral Thesis

Unpublished

Standard

Harvard

Reen, G 2017, 'Benefit and Risk Information for Medication in Multiple Sclerosis (BRIMMS)', Ph.D., Royal Holloway, University of London.

APA

Vancouver

Author

BibTeX

@phdthesis{297fdd614b8f44329260b21b060062f6,
title = "Benefit and Risk Information for Medication in Multiple Sclerosis (BRIMMS)",
keywords = "Multiple Sclerosis, understanding, education, risk perception, treatment risk, treatment benefit, shared decision-making, medical decision-making, formats, communication",
author = "Gurpreet Reen",
year = "2017",
language = "English",
school = "Royal Holloway, University of London",

}

RIS

TY - THES

T1 - Benefit and Risk Information for Medication in Multiple Sclerosis (BRIMMS)

AU - Reen, Gurpreet

PY - 2017

Y1 - 2017

KW - Multiple Sclerosis

KW - understanding

KW - education

KW - risk perception

KW - treatment risk

KW - treatment benefit

KW - shared decision-making

KW - medical decision-making

KW - formats

KW - communication

M3 - Doctoral Thesis

ER -